Treatment and bioluminescent visualization using multimodal TRAIL molecules
AssigneeThe General Hospital Corporation
InventorKhalid Shah
Life of this patent
Estimating the term…
Abstract
Described herein are novel compositions comprising multimodal TRAIL agents and cells engineered to express such multimodal TRAIL agents, including cells encapsulated in a scaffold or matrix, for use in the treatment of disorders such as cancer.
Claims13
A method of treatment and bioluminescent visualization for a subject having a malignant condition comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a soluble TRAIL fusion protein comprising, in the following N-terminal to C-terminal order, a reporter module, a linker module of at least 8 amino acids, and a therapeutic TRAIL module, wherein said therapeutic TRAIL module comprises an extracellular domain of human TRAIL of SEQ ID NO:
- 1, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.